University of Cambridge Enterprise

Summary

University of Cambridge Enterprise appeared to be the Corporate Investor, which was created in 2006. The company was established in Europe in United Kingdom. The leading representative office of defined Corporate Investor is situated in the Cambridge.

Besides them, we counted 4 critical employees of this fund in our database.

Among the most popular fund investment industries, there are Health Care, Medical. Among the most popular portfolio startups of the fund, we may highlight Cambridge Epigenetix, Carrick Therapeutics, Colorifix. For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.

The real fund results show that this Corporate Investor is 22 percentage points more often commits exit comparing to other companies. The important activity for fund was in 2016. Despite it in 2019 the fund had an activity. Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is constantly included in 2-6 investment rounds annually. The increased amount of exits for fund were in 2018. This University of Cambridge Enterprise works on 21 percentage points less the average amount of lead investments comparing to the other organizations.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the University of Cambridge Enterprise, startups are often financed by Amadeus Capital Partners, SBRI Healthcare, Roche Venture Fund. The meaningful sponsors for the fund in investment in the same round are Amadeus Capital Partners, Cambridge Angels group, Martlet. In the next rounds fund is usually obtained by Cambridge Innovation Capital, Cambridge Angels group, Amadeus Capital Partners.